JP2012528796A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012528796A5 JP2012528796A5 JP2012513346A JP2012513346A JP2012528796A5 JP 2012528796 A5 JP2012528796 A5 JP 2012528796A5 JP 2012513346 A JP2012513346 A JP 2012513346A JP 2012513346 A JP2012513346 A JP 2012513346A JP 2012528796 A5 JP2012528796 A5 JP 2012528796A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- beta
- binding
- coronary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18267909P | 2009-05-29 | 2009-05-29 | |
| US61/182,679 | 2009-05-29 | ||
| US25257109P | 2009-10-16 | 2009-10-16 | |
| US61/252,571 | 2009-10-16 | ||
| US31300110P | 2010-03-11 | 2010-03-11 | |
| US61/313,001 | 2010-03-11 | ||
| PCT/US2010/036761 WO2010138939A1 (en) | 2009-05-29 | 2010-05-28 | CARDIOVASCULAR RELATED USES OF IL-1ß ANTIBODIES AND BINDING FRAGMENTS THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015000602A Division JP2015120704A (ja) | 2009-05-29 | 2015-01-06 | ＩＬ−１β抗体およびその結合断片の心血管関連の使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012528796A JP2012528796A (ja) | 2012-11-15 |
| JP2012528796A5 true JP2012528796A5 (https=) | 2013-07-18 |
| JP5763625B2 JP5763625B2 (ja) | 2015-08-12 |
Family
ID=43223130
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012513346A Expired - Fee Related JP5763625B2 (ja) | 2009-05-29 | 2010-05-28 | ＩＬ−１β抗体およびその結合断片の心血管関連の使用 |
| JP2015000602A Pending JP2015120704A (ja) | 2009-05-29 | 2015-01-06 | ＩＬ−１β抗体およびその結合断片の心血管関連の使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015000602A Pending JP2015120704A (ja) | 2009-05-29 | 2015-01-06 | ＩＬ−１β抗体およびその結合断片の心血管関連の使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US20100316651A1 (https=) |
| EP (1) | EP2435073A4 (https=) |
| JP (2) | JP5763625B2 (https=) |
| KR (1) | KR20120061041A (https=) |
| CN (2) | CN102573893A (https=) |
| AU (1) | AU2010253924B2 (https=) |
| BR (1) | BRPI1011228A2 (https=) |
| CA (1) | CA2763161A1 (https=) |
| EA (1) | EA201101643A1 (https=) |
| HK (1) | HK1245111A1 (https=) |
| IL (1) | IL216660A0 (https=) |
| MX (1) | MX2011012666A (https=) |
| NZ (1) | NZ597024A (https=) |
| SG (3) | SG176265A1 (https=) |
| WO (1) | WO2010138939A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2832066C (en) * | 2011-04-01 | 2023-04-18 | The Medicines Company | Short-acting dihydropyridines (clevidipine) for use in reducing stroke damage |
| BR112014007253A2 (pt) * | 2011-09-30 | 2017-03-28 | Novartis Ag | uso de anticorpos que se ligam a il-1beta |
| ES2534782T3 (es) * | 2012-02-02 | 2015-04-28 | Baylor College Of Medicine | Sistema biológico de administración y expresión basado en adenovirus para uso en el tratamiento de la osteoartritis |
| CN103588878A (zh) * | 2012-08-15 | 2014-02-19 | 江苏泰康生物医药有限公司 | 一种人源化抗人白细胞介素1 β单克隆抗体及其制备与应用 |
| CN113018431A (zh) * | 2012-10-04 | 2021-06-25 | 詹森生物科技公司 | 治疗血管疾病及其并发症 |
| AU2013344796B2 (en) * | 2012-11-16 | 2016-11-10 | Novartis Ag | Use of IL-1 beta binding antibodies for treating peripheral arterial disease |
| US10000557B2 (en) * | 2012-12-19 | 2018-06-19 | Dnae Group Holdings Limited | Methods for raising antibodies |
| CN103059136A (zh) * | 2012-12-24 | 2013-04-24 | 浙江大学 | 抗中华鳖IL-1β多克隆抗体的制备及在检测中的应用 |
| KR102337954B1 (ko) * | 2018-08-16 | 2021-12-10 | 차의과학대학교 산학협력단 | 뇌졸중 치료용 조성물 및 이를 스크리닝하는 방법 |
| EP3965819A4 (en) * | 2019-05-03 | 2023-07-12 | University of Zürich | TREATMENT OF CEREBRAL ISCHEMIA-REPERFUSION INJURY |
| US20220275079A1 (en) * | 2020-11-20 | 2022-09-01 | The General Hospital Corporation | Clonal Hematopoiesis and Risk of Chronic Liver Disease |
| GB202400340D0 (en) | 2024-01-10 | 2024-02-21 | Wotherspoon Hugh Robert | IL-1B binding antibody |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7820383B2 (en) | 1997-03-10 | 2010-10-26 | Interleukin Genetics, Inc. | Method for diagnosing myocardial infarction |
| AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
| US6635249B1 (en) * | 1999-04-23 | 2003-10-21 | Cenes Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
| US7860583B2 (en) * | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
| CA2440387A1 (en) * | 2001-03-23 | 2002-10-03 | Durect Corporation | Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| US20040106954A1 (en) * | 2002-11-15 | 2004-06-03 | Whitehurst Todd K. | Treatment of congestive heart failure |
| US20040224893A1 (en) | 2003-05-06 | 2004-11-11 | Li-Hsien Wang | Methods of using IL-1 antagonists to treat neointimal hyperplasia |
| EP1851245B1 (en) * | 2005-01-26 | 2012-10-10 | Amgen Fremont Inc. | Antibodies against interleukin-1 beta |
| US20060171948A1 (en) * | 2005-02-02 | 2006-08-03 | Weinstein Steven P | Methods of using IL-1 antagonists to reduce C-reactive protein |
| WO2006084145A2 (en) * | 2005-02-02 | 2006-08-10 | Regeneron Pharmaceuticals, Inc. | Methods of using il-1 antagonists to reduce c-reactive protein |
| EP3479844B1 (en) | 2005-04-15 | 2023-11-22 | MacroGenics, Inc. | Covalent diabodies and uses thereof |
| DK1899378T3 (da) * | 2005-06-21 | 2010-02-01 | Xoma Technology Ltd | IL-1 beta-bindende antistoffer og fragmenter deraf |
| US20100015146A1 (en) | 2005-10-14 | 2010-01-21 | Novo Nordisk A/S | Treating diabetes using inhibitors of il-1 |
| JP4524275B2 (ja) * | 2006-09-01 | 2010-08-11 | 日本ポリプロ株式会社 | ビニル基および極性基含有プロピレン系共重合体及びそれを用いる重合体の製造方法。 |
| CA2673592C (en) * | 2006-12-20 | 2014-03-25 | Xoma Technology Ltd. | Methods for the treatment of il-1.beta. related diseases |
-
2010
- 2010-05-28 CA CA2763161A patent/CA2763161A1/en not_active Abandoned
- 2010-05-28 SG SG2011087723A patent/SG176265A1/en unknown
- 2010-05-28 JP JP2012513346A patent/JP5763625B2/ja not_active Expired - Fee Related
- 2010-05-28 AU AU2010253924A patent/AU2010253924B2/en not_active Ceased
- 2010-05-28 EA EA201101643A patent/EA201101643A1/ru unknown
- 2010-05-28 KR KR1020117031198A patent/KR20120061041A/ko not_active Withdrawn
- 2010-05-28 CN CN2010800330317A patent/CN102573893A/zh active Pending
- 2010-05-28 US US12/790,738 patent/US20100316651A1/en not_active Abandoned
- 2010-05-28 EP EP10781360A patent/EP2435073A4/en not_active Withdrawn
- 2010-05-28 CN CN201710537454.6A patent/CN107243077A/zh active Pending
- 2010-05-28 WO PCT/US2010/036761 patent/WO2010138939A1/en not_active Ceased
- 2010-05-28 SG SG2014014534A patent/SG2014014534A/en unknown
- 2010-05-28 NZ NZ597024A patent/NZ597024A/en not_active IP Right Cessation
- 2010-05-28 BR BRPI1011228A patent/BRPI1011228A2/pt not_active IP Right Cessation
- 2010-05-28 MX MX2011012666A patent/MX2011012666A/es active IP Right Grant
- 2010-05-28 SG SG10201500180RA patent/SG10201500180RA/en unknown
-
2011
- 2011-11-28 IL IL216660A patent/IL216660A0/en unknown
-
2015
- 2015-01-06 JP JP2015000602A patent/JP2015120704A/ja active Pending
-
2017
- 2017-07-11 US US15/647,203 patent/US10611832B2/en active Active
-
2018
- 2018-04-09 HK HK18104608.6A patent/HK1245111A1/zh unknown
-
2020
- 2020-02-24 US US16/799,707 patent/US20210009679A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012528796A5 (https=) | ||
| EP3762026B1 (en) | Use of pcsk9 inhibitor for reducing cardiovascular risk | |
| JP2017509624A5 (https=) | ||
| JP2021515772A5 (https=) | ||
| JP2023071715A (ja) | アテローム動脈硬化性心血管疾患を含むアテローム性動脈硬化症の併用療法 | |
| JP2014516953A5 (https=) | ||
| Tziomalos et al. | Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review | |
| JP2026020250A (ja) | アテローム性動脈硬化性心血管疾患を治療するための医薬化合物 | |
| CN119564834A (zh) | 度拉糖肽的治疗用途 | |
| Bach | Adjunctive pharmacologic therapies in acute myocardial infarction | |
| Polonsky et al. | Reducing the residual risk of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor therapy with combination therapy | |
| Ott et al. | Rosuvastatin does not affect intrarenal hemodynamics in patients with hypercholesterolemia | |
| Robson | Iron supplementation reduces re-hospitalization for heart failure | |
| Tamargo et al. | Cardiovascular pharmacotherapy in year in 2025 | |
| Jonas Häner et al. | Evolocumab for Early Reduction of LDL-Cholesterol Levels in Patients with Acute Coronary Syndromes (EVOPACS) | |
| Kim et al. | Monotherapy versus combination therapy of statin and renin–angiotensin system inhibitor in ST-segment elevation myocardial infarction | |
| Lin et al. | From ASCOT to Asia: A More Active and Successful Approach in Preventing Cardiovascular Disease | |
| EA049586B1 (ru) | Средства комбинированной терапии атеросклероза, включая атеросклеротическое сердечно-сосудистое заболевание | |
| AU2021236807A1 (en) | Method for treating cholesterol-related diseases | |
| Tonkin et al. | Lipid-lowering agents: Andrew M. Tonkin and Omar Farouque Overview of clinical trials | |
| Furst et al. | Systemic Sclerosis: Current and future prospects in management | |
| Fuchs | Itsik Ben-Dor1, 2, Ran Kornowski1, 2, & | |
| NZ794398A (en) | Combined Therapies For Atherosclerosis, Including Atherosclerotic Cardiovascular Disease | |
| Sarma et al. | Antithrombotic Therapy | |
| TH2001001181A (th) | วิธีการสำหรับการบำบัดโรคที่เกี่ยวข้องกับ-tnf |